Large-scale testing (Phase 3)Study completedNCT00250276
What this trial is testing
Evaluation of the Immune Responses of GSK Biologicals' HPV Vaccine Following Manufacturing Process Adaptation.
Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 798